Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance and exercise status of the 20th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued through a third-party allotment
発行・処分する株式数
1,000,000 new shares (7 July 2026)
Existing Shares and Increase
+0.36%Rate of increase
281,667,319 shares282,667,319Shares
The monthly number of shares delivered was approximately 0.36% of the 281,667,319 issued shares (no dilution rate was stated in the filing)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥24.00 or ¥24.70 (as stated in the exercise status for the covered month; details and floor of the adjustment clause: Not disclosed)
Number of Stock Acquisition Rights
Total issued: 590,000 rights (calculated from an exercise ratio of 1.69% for 10,000 rights); exercised during the covered month: 10,000 rights; unexercised at the end of the preceding month: 429,499 rights; currently unexercised: 419,499 rights
Procedures under the Corporate Code of Conduct
Under the status of compliance with exercise restrictions, the filing states the status of compliance with the exercise period pursuant to Article 434 of the Listing Regulations. The number of shares delivered, aggregating all series, was 1,000,000, compared with 264,729,198 listed shares as of the payment date for the issuance, resulting in an exercise ratio related to the exercise restriction of 0.38%.
Most recent equity financing
The 20th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 23 December 2025
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance and exercise status of the 20th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued through a third-party allotment |
| Number of shares to be issued or disposed of | 1,000,000 new shares (7 July 2026) |
| Dilution Rate | The monthly number of shares delivered was approximately 0.36% of the 281,667,319 issued shares (no dilution rate was stated in the filing) |
| Total number of issued shares | 281,667,319 shares (as of the end of the month preceding the covered period) → 282,667,319 shares (after exercise in July 2026, calculated from the number of shares delivered stated in the filing) |
| Exercise price | ¥24.00 or ¥24.70 (as stated in the exercise status for the covered month; details and floor of the adjustment clause: Not disclosed) |
| Number of Stock Acquisition Rights | Total issued: 590,000 rights (calculated from an exercise ratio of 1.69% for 10,000 rights); exercised during the covered month: 10,000 rights; unexercised at the end of the preceding month: 429,499 rights; currently unexercised: 419,499 rights |
| Procedures under the Corporate Code of Conduct | Under the status of compliance with exercise restrictions, the filing states the status of compliance with the exercise period pursuant to Article 434 of the Listing Regulations. The number of shares delivered, aggregating all series, was 1,000,000, compared with 264,729,198 listed shares as of the payment date for the issuance, resulting in an exercise ratio related to the exercise restriction of 0.38%. |
| Most recent equity financing | The 20th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 23 December 2025 |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in July 2026 of the 20th Series of Stock Acquisition Rights issued on 23 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.